Skip to main content
. 2020 Nov 3;14(1):100926. doi: 10.1016/j.tranon.2020.100926

Fig. 1.

Fig. 1

Effects of Cisplatin and Fingolimod on TNBC in 2D cell viability assay.

A-C. Dose-response effect of Cisplatin and Fingolimod treatment on MDA-MB-231-RFP-Luc, 4T1, and BT20 TNBC using MTS incorporation cell viability assay.

The study was performed with three to four replicates from three to five independent experiments. Data represent mean and SD. Statistical differences between the groups were determined using one-way ANOVA followed by Bonferroni's multiple comparisons test (vs. control, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001).